Pfizer CEO Albert Bourla told The Atlantic’s Craig Melvin the company expects the FDA to approve its Coronavirus vaccine shots for “between 2 and 5 [years old]… before the end of the year'”
Pfizer CEO Albert Bourla told The Atlantic’s Craig Melvin the company expects the FDA to approve its Coronavirus vaccine shots for “between 2 and 5 [years old]… before the end of the year'”